Osteoarthritis is a painful condition of the joints that often lead to disability, especially as people age. The condition slowly damages the cartilage in virtually any joint, which means that bone ends up grinding against bone. This ultimately leads to the loss of synovial fluid, muscle tissue and even damages the bones themselves. Pain and restricted movement are very common.

For a person with osteoarthritis, finding effective treatment and relief is important, as is finding ways to halt the progression of the disease before it worsens. A study on a new osteoarthritis treatment indicates that there are some significant strides being made in that direction. 

Knee injection study promises new hope for patients with osteoarthritis

A new study looking into whether an epidermal growth factor receptor deficiency might accelerate the effects of this condition. The findings show that using nanomedicine through targeted knee injections might help to halt the effects of osteoarthritis. 

While there aren’t any cures for this disease, being able to prevent more damage from occurring and using other treatments might provide those who suffer from this painful condition with more relief than what’s currently possible.  

Previous studies into epidermal growth factor receptor deficiencies have proven to be controversial in the past. This study differs from those because it’s shown consistent results for people who have osteoarthritis of the knee. 

When osteoarthritis becomes disabling, it’s okay to seek help

Individuals who have osteoarthritis might be unable to work because of the effects of the condition. Fighting for Social Security Disability benefits isn’t always easy, however. Working with a lawyer who is familiar with this area of the law might be beneficial.